ARCHIVES

CIIT’s Swenberg Denies He Is NTP “Industry Representative”

This article is from The Cancer Letter archive.

Vol. 06 No. 49 | December 12, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Funding opportunities listed.

February 20, 2004

CTAC Discussion, Group Chairs Comment

December 17, 2010

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994

Continuing Resolution Funds Agencies Through Dec. 5.

November 17, 2000

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001